IndraLab
Statements
reach
"Ocaranza, M. P.; Godoy, I.; Jalil, J. E.; Varas, M.; Collantes, P.; Pinto, M.; Roman, M.; Ramirez, C.; Copaja, M.; DiazAraya, G.; Castro, P.; Lavandero, S., 2006 : Enalapril attenuates downregulation of Angiotensin converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat."
reach
"While enalapril dose-dependently decreased mean arterial pressure, the cardiac index and PaO /FiO ratio were higher in patients treated with enalapril than in the control group.After a successful phase I study of pharmacokinetics and pharmacodynamics of recombinant human (rh)ACE2 in healthy volunteers (Haschke et al., 2013), a clinical trial in patients with ARDS was terminated prematurely because the predefined effects on outcome were not achieved (Khan et al., 2017)."
reach
"Similarly to how ACE2 receptor inhibitors reduced SARS-CoV-1-induced acute respiratory distress syndrome (ARDS) [17], it seems that efforts to develop ACE2 receptor inhibitors (also known as ACE2 blockers such as enalapril, lisinopril, captopril, perindopril [18], [19]) for SARS-CoV-2 may be beneficial (Fig. 1
A)."
| PMC